Sensorineural hearing loss. Conductive and sensorineural hearing loss
Conditions
Interventions
Intervention 1: Intervention group: The basic treatment for sensorineural hearing loss will include intra-ear dexamethasone injections 3 to 5 times at 5-day intervals or oral prednisolone tablets. In
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age between 18-70 years Sensorineural hearing loss of at least 30 dB in at least 3 consecutive frequencies that has developed in less than 72 hours Patient consent to participate in the study
Exclusion criteria
Exclusion criteria: History of any ear disease History of calcium, vitamin, and magnesium intake two months before intervention Conductive hearing loss More than two weeks have passed since the onset of symptoms
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improving sudden sensorineural hearing loss. Timepoint: Before starting treatment, the second week, the fourth week, and the twelfth week after starting treatment. Method of measurement: Audiometric test and examination of SRT, SDS and PTA parameters. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life related to hearing loss. Timepoint: Before starting treatment, the second week, the fourth week, and the twelfth week after starting treatment. Method of measurement: By asking a question about the extent to which hearing loss affects the patient's quality of life in communicating with friends, family, and colleagues using a Likert scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Moradi
Hamedan University of Medical Sciences
Outcome results
None listed